{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:38:49Z","timestamp":1776303529742,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Merz Pharmaceuticals GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12955-017-0804-8","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T03:46:55Z","timestamp":1511840815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Initial psychometric validation of the questionnaire on pain caused by spasticity (QPS)"],"prefix":"10.1186","volume":"15","author":[{"given":"Thorin L.","family":"Geister","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald M.","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Heilbronn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,28]]},"reference":[{"key":"804_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PEP.0b013e3181ccbabb","volume":"22","author":"S Doralp","year":"2010","unstructured":"Doralp S, Bartlett DJ. The prevalence, distribution, and effect of pain among adolescents with cerebral palsy. Pediatr Phys Ther. 2010;22:26\u201333.","journal-title":"Pediatr Phys Ther"},{"key":"804_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0304-3959(02)00123-9","volume":"99","author":"KL Hadden","year":"2002","unstructured":"Hadden KL, von Baeyer CL. Pain in children with cerebral palsy: common triggers and expressive behaviors. Pain. 2002;99:281\u20138.","journal-title":"Pain"},{"key":"804_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00431-012-1720-x","volume":"172","author":"M Massaro","year":"2013","unstructured":"Massaro M, Pastore S, Ventura A, Barbi E. Pain in cognitively impaired children: a focus for general pediatricians. Eur J Pediatr. 2013;172:9\u201314.","journal-title":"Eur J Pediatr"},{"key":"804_CR4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1651-2227.2009.01626.x","volume":"99","author":"KN Parkinson","year":"2010","unstructured":"Parkinson KN, Gibson L, Dickinson HO, Colver AF. Pain in children with cerebral palsy: a cross-sectional multicentre European study. Acta Paediatr. 2010;99:446\u201351.","journal-title":"Acta Paediatr"},{"key":"804_CR5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3109\/09638288.2012.656794","volume":"34","author":"K Ramstad","year":"2012","unstructured":"Ramstad K, Jahnsen R, Skjeldal OH, Diseth TH. Mental health, health related quality of life and recurrent musculoskeletal pain in children with cerebral palsy 8-18 years old. Disabil Rehabil. 2012;34:1589\u201395.","journal-title":"Disabil Rehabil"},{"key":"804_CR6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(14)61229-0","volume":"385","author":"A Colver","year":"2015","unstructured":"Colver A, Rapp M, Eisemann N, Ehlinger V, Thyen U, Dickinson HO, et al. Self-reported quality of life of adolescents with cerebral palsy: a cross-sectional and longitudinal analysis. Lancet. 2015;385:705\u201316.","journal-title":"Lancet"},{"key":"804_CR7","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/S0140-6736(07)61013-7","volume":"369","author":"HO Dickinson","year":"2007","unstructured":"Dickinson HO, Parkinson KN, Ravens-Sieberer U, Schirripa G, Thyen U, Arnaud C, et al. Self-reported quality of life of 8-12-year-old children with cerebral palsy: a cross-sectional European study. Lancet. 2007;369:2171\u20138.","journal-title":"Lancet"},{"key":"804_CR8","doi-asserted-by":"crossref","unstructured":"Penner M, Xie WY, Binepal N, Switzer L, Fehlings D. Characteristics of pain in children and youth with cerebral palsy. Pediatrics. 2013;","DOI":"10.1542\/peds.2013-0224"},{"key":"804_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(11)70176-4","volume":"10","author":"ML Aisen","year":"2011","unstructured":"Aisen ML, Kerkovich D, Mast J, Mulroy S, Wren TA, Kay RM, et al. Cerebral palsy: clinical care and neurological rehabilitation. Lancet Neurol. 2011;10:844\u201352.","journal-title":"Lancet Neurol"},{"key":"804_CR10","unstructured":"Centers for Disease Control and Prevention: Facts about Cerebral Palsy [ http:\/\/www.cdc.gov\/ncbddd\/cp\/facts.html ]."},{"key":"804_CR11","first-page":"91","volume":"73","author":"KW Krigger","year":"2006","unstructured":"Krigger KW. Cerebral palsy: an overview. Am Fam Physician. 2006;73:91\u2013100.","journal-title":"Am Fam Physician"},{"key":"804_CR12","doi-asserted-by":"crossref","unstructured":"SCPE: Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol 2002, 44:633\u2013640.","DOI":"10.1111\/j.1469-8749.2002.tb00848.x"},{"key":"804_CR13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejpn.2010.04.006","volume":"15","author":"E Chaleat-Valayer","year":"2011","unstructured":"Chaleat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Berard C, et al. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE. Eur J Paediatr Neurol. 2011;15:439\u201348.","journal-title":"Eur J Paediatr Neurol"},{"key":"804_CR14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1469-8749.2011.04070.x","volume":"53","author":"K Ramstad","year":"2011","unstructured":"Ramstad K, Jahnsen R, Skjeldal OH, Diseth TH. Characteristics of recurrent musculoskeletal pain in children with cerebral palsy aged 8 to 18 years. Developmental Medicine & Child Neurology. 2011;53:1013\u20138.","journal-title":"Developmental Medicine & Child Neurology"},{"key":"804_CR15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11136-013-0526-2","volume":"23","author":"TL Geister","year":"2014","unstructured":"Geister TL, Quintanar-Solares M, Martin M, Aufhammer S, Asmus F. Qualitative development of the 'Questionnaire on pain caused by spasticity (QPS),' a pediatric patient-reported outcome for spasticity-related pain in cerebral palsy. Qual Life Res. 2014;23:887\u201396.","journal-title":"Qual Life Res"},{"key":"804_CR16","doi-asserted-by":"crossref","unstructured":"Brashear A, Elovic EP, Earl NL, Liu C, Dimitrova R. OnabotulinumtoxinA treatment reduces pain in patients with upper limb post-stroke spasticity. In American Academy of physical medicine and rehabilitation annual assembly 2014. San Diego, USA: American Academy of physical medicine and. Rehabilitation. 2014;","DOI":"10.1016\/j.pmrj.2014.08.773"},{"key":"804_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PHM.0b013e31824fa9ca","volume":"91","author":"A Esquenazi","year":"2012","unstructured":"Esquenazi A, Mayer N, Lee S, Brashear A, Elovic E, Francisco GE, et al. Patient registry of outcomes in spasticity care. Am J Phys Med Rehabil. 2012;91:729\u201346.","journal-title":"Am J Phys Med Rehabil"},{"key":"804_CR18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.110.582197","volume":"42","author":"LC Shaw","year":"2011","unstructured":"Shaw LC, Price CI, van Wijck FM, Shackley P, Steen N, Barnes MP, et al. Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain. Stroke. 2011;42:1371\u20139.","journal-title":"Stroke"},{"key":"804_CR19","first-page":"119","volume":"24","author":"V Kantzer","year":"2015","unstructured":"Kantzer V, Basse S, Martin ML, Geister TL. Linguistic validation interviews in a pediatric cerebral palsy population: approaches for meaningful feedback abstract. Qual Life Res. 2015;24:119.","journal-title":"Qual Life Res"},{"key":"804_CR20","unstructured":"Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims [ http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf . ]."},{"key":"804_CR21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","volume":"16","author":"LS Matza","year":"2013","unstructured":"Matza LS, Patrick DL, Riley AW, Alexander JJ, Rajmil L, Pleil AM, et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health. 2013;16:461\u201379.","journal-title":"Value Health"},{"key":"804_CR22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument. Value Health. 2011;14:967\u201377.","journal-title":"Value Health"},{"key":"804_CR23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2--assessing respondent understanding. Value Health. 2011;14:978\u201388.","journal-title":"Value Health"},{"key":"804_CR24","doi-asserted-by":"crossref","first-page":"A39","DOI":"10.1016\/j.jval.2013.03.224","volume":"16","author":"AJ Bryant","year":"2013","unstructured":"Bryant AJ, Quintanar-Solares M, Ascoytia CM, Martin ML, Asmus F, Geister TL. Conducting qualitative interviews in compromised child populations: cerebral palsy (CP) as a case study. Value Health. 2013;16:A39.","journal-title":"Value Health"},{"key":"804_CR25","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1016\/j.jval.2013.03.249","volume":"16","author":"ML Martin","year":"2013","unstructured":"Martin ML, Quintanar-Solares M, Asmus F, Geister TL. Designing corresponding assessments for children and parents to improve data capture in special populations. Value Health. 2013;16:A44.","journal-title":"Value Health"},{"key":"804_CR26","doi-asserted-by":"crossref","first-page":"A41","DOI":"10.1016\/j.jval.2013.03.232","volume":"16","author":"M Quintanar-Solares","year":"2013","unstructured":"Quintanar-Solares M, Martin ML, Bryant AJ, Ascoytia CM, Asmus F, Geister TL. Using questionnaire design to explore reporting differences for spasticity related pain in children and adolescents with cerebral palsy. Value Health. 2013;16:A41.","journal-title":"Value Health"},{"key":"804_CR27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S0012162206001162","volume":"48","author":"AC Eliasson","year":"2006","unstructured":"Eliasson AC, Krumlinde-Sundholm L, Rosblad B, Beckung E, Arner M, Ohrvall AM, et al. The manual ability classification system (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006;48:549\u201354.","journal-title":"Dev Med Child Neurol"},{"key":"804_CR28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1469-8749.2008.03089.x","volume":"50","author":"RJ Palisano","year":"2008","unstructured":"Palisano RJ, Rosenbaum P, Bartlett D, Livingston MH. Content validity of the expanded and revised gross motor function classification system. Dev Med Child Neurol. 2008;50:744\u201350.","journal-title":"Dev Med Child Neurol"},{"key":"804_CR29","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.288.11.1357","volume":"288","author":"PL Rosenbaum","year":"2002","unstructured":"Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P, et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA. 2002;288:1357\u201363.","journal-title":"JAMA"},{"key":"804_CR30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/80.9.873","volume":"80","author":"DJ Russell","year":"2000","unstructured":"Russell DJ, Avery LM, Rosenbaum PL, Raina PS, Walter SD, Palisano RJ. Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. Phys Ther. 2000;80:873\u201385.","journal-title":"Phys Ther"},{"key":"804_CR31","first-page":"540","volume":"192","author":"B Ashworth","year":"1964","unstructured":"Ashworth B. Preliminary trial of Carisoprodol in multiple sclerosis. Practitioner. 1964;192:540\u20132.","journal-title":"Practitioner"},{"key":"804_CR32","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1468-1331.1999.tb00031.x","volume":"6","author":"RN Boyd","year":"1999","unstructured":"Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type a for the management of children with cerebral palsy. Eur J Neurol. 1999;6:S23\u201335.","journal-title":"Eur J Neurol"},{"key":"804_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1179\/108331902125001770","volume":"7","author":"S Morris","year":"2002","unstructured":"Morris S. Ashworth and Tardieu scales: their clinical relevance for measuring spasticity in adult and paediatric neurological populations. Phys Ther Rev. 2002;7:53\u201362.","journal-title":"Phys Ther Rev"},{"key":"804_CR34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S001216220600096X","volume":"48","author":"JW Varni","year":"2006","unstructured":"Varni JW, Burwinkle TM, Berrin SJ, Sherman SA, Artavia K, Malcarne VL, et al. The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the generic Core scales and cerebral palsy module. Dev Med Child Neurol. 2006;48:442\u20139.","journal-title":"Dev Med Child Neurol"},{"key":"804_CR35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11136-010-9751-0","volume":"20","author":"X Yang","year":"2011","unstructured":"Yang X, Xiao N, Yan J. The PedsQL in pediatric cerebral palsy: reliability and validity of the Chinese version pediatric quality of life inventory 4.0 generic core scales and 3.0 cerebral palsy module. Qual Life Res. 2011;20:243\u201352.","journal-title":"Qual Life Res"},{"key":"804_CR36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","volume":"8","author":"D Wild","year":"2005","unstructured":"Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94\u2013104.","journal-title":"Value Health"},{"key":"804_CR37","unstructured":"Nunnaly J, Bernstein I: Psychometric Theory. 3rd edition edn: McGraw-Hill; 1994."},{"key":"804_CR38","volume-title":"Applied multivariate statistics for the social sciences","author":"JP Stevens","year":"1992","unstructured":"Stevens JP. Applied multivariate statistics for the social sciences. 2nd ed. Hillsdale: NJ:Erlbaum; 1992.","edition":"2"},{"key":"804_CR39","unstructured":"Andrich D, Sheridan B, Luo G: Perth: RUMM Laboratory; 2030. Rasch Unidimensional Measurement Model [Computer software] 2008."},{"key":"804_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02289113","volume":"16","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ, Warrington WG. Time-limit tests: estimating their reliability and degree of speeding. Psychometrika. 1951;16:167\u201388.","journal-title":"Psychometrika"},{"key":"804_CR41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420\u20138.","journal-title":"Psychol Bull"},{"key":"804_CR42","unstructured":"SPSS Inc. Released 2009. PASW statistics for windows, version 18.0. Chicago: SPSS Inc."},{"key":"804_CR43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"804_CR44","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jpepsy\/jsm103","volume":"33","author":"LL Cohen","year":"2008","unstructured":"Cohen LL, Lemanek K, Blount RL, Dahlquist LM, Lim CS, Palermo TM, et al. Evidence-based assessment of pediatric pain. J Pediatr Psychol. 2008;33:939\u201355. discussion 956-937","journal-title":"J Pediatr Psychol"},{"key":"804_CR45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/cdev.12006","volume":"84","author":"V Heather Fritzley","year":"2013","unstructured":"Heather Fritzley V, Lindsay RC, Lee K. Young children's response tendencies toward yes-no questions concerning actions. Child Dev. 2013;84:711\u201325.","journal-title":"Child Dev"},{"key":"804_CR46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2307\/1130193","volume":"56","author":"C Edelbrock","year":"1985","unstructured":"Edelbrock C, Costello AJ, Dulcan MK, Kalas R, Conover NC. Age differences in the reliability of the psychiatric interview of the child. Child Dev. 1985;56:265\u201375.","journal-title":"Child Dev"},{"key":"804_CR47","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1037\/1040-3590.8.4.350","volume":"8","author":"N Schmitt","year":"1996","unstructured":"Schmitt N. Uses and abuses of coefficient alpha. Psychol Assess. 1996;8:350.","journal-title":"Psychol Assess"},{"key":"804_CR48","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/09638280500404305","volume":"28","author":"AB Haugh","year":"2006","unstructured":"Haugh AB, Pandyan AD, Johnson GR. A systematic review of the Tardieu scale for the measurement of spasticity. Disabil Rehabil. 2006;28:899\u2013907.","journal-title":"Disabil Rehabil"},{"key":"804_CR49","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/0883073810362266","volume":"25","author":"AA Alhusaini","year":"2010","unstructured":"Alhusaini AA, Dean CM, Crosbie J, Shepherd RB, Lewis J. Evaluation of spasticity in children with cerebral palsy using Ashworth and Tardieu scales compared with laboratory measures. J Child Neurol. 2010;25:1242\u20137.","journal-title":"J Child Neurol"},{"key":"804_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1469-8749.2004.tb00490.x","volume":"46","author":"CM Houlihan","year":"2004","unstructured":"Houlihan CM, O'Donnell M, Conaway M, Stevenson RD. Bodily pain and health-related quality of life in children with cerebral palsy. Dev Med Child Neurol. 2004;46:305\u201310.","journal-title":"Dev Med Child Neurol"},{"key":"804_CR51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.280.2.147","volume":"280","author":"O Gureje","year":"1998","unstructured":"Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA. 1998;280:147\u201351.","journal-title":"JAMA"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-017-0804-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T23:44:26Z","timestamp":1603410266000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-017-0804-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,28]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1186\/s12955-017-0804-8","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,28]]},"article-number":"229"}}